<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">19094200</PMID>
        <DateCompleted>
            <Year>2009</Year>
            <Month>03</Month>
            <Day>27</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1744-8069</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>4</Volume>
                    <PubDate>
                        <Year>2008</Year>
                        <Month>Dec</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular pain</Title>
                <ISOAbbreviation>Mol Pain</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain.</ArticleTitle>
            <Pagination>
                <MedlinePgn>64</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/1744-8069-4-64</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Genetic variation contributes to differences in pain sensitivity and response to different analgesics. Catecholamines are involved in the modulation of pain and are partly metabolized by the catechol-O-methyltransferase (COMT) enzyme. Genetic variability in the COMT gene may therefore contribute to differences in pain sensitivity and response to analgesics. It is shown that a polymorphism in the COMT gene, Rs4680 (Val158Met), influence pain sensitivity in human experimental pain and the efficacy for morphine in cancer pain treatment. In this study we wanted to investigate if variability in other regions in the COMT gene also contributes to interindividual variability in morphine efficacy.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">We genotyped 11 single nucleotide polymorphisms (SNPs) throughout the COMT gene, and constructed haplotypes from these 11 SNPs, which were in Hardy-Weinberg equilibrium. We compared both genotypes and haplotypes against pharmacological, demographical and patient symptoms measurements in a Caucasian cancer patient cohort (n = 197) receiving oral morphine treatment for cancer pain. There were two frequent haplotypes (34.5% and 17.8%) in our cohort. Multivariate analyses showed that patients carrying the most frequent haplotype (34.5%) needed lower morphine doses than patients not carrying the haplotype, with a reduction factor of 0.71 (p = 0.005). On the allele level, carriers of alleles for six of the SNPs show weak associations in respect to morphine dose and the alleles associated with the lowest morphine doses constitute part of the most frequent haplotype.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study suggests that genetic variability in the COMT gene influence the efficacy of morphine in cancer patients with pain, and that increased understanding of this variability is reached by expanding from analyses of single SNPs to haplotype construction and analyses.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rakvåg</LastName>
                    <ForeName>Trude T</ForeName>
                    <Initials>TT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. trude.rakvag@ntnu.no</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ross</LastName>
                    <ForeName>Joy R</ForeName>
                    <Initials>JR</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sato</LastName>
                    <ForeName>Hiroe</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Skorpen</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaasa</LastName>
                    <ForeName>Stein</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Klepstad</LastName>
                    <ForeName>Pål</ForeName>
                    <Initials>P</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2008</Year>
                <Month>12</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mol Pain</MedlineTA>
            <NlmUniqueID>101242662</NlmUniqueID>
            <ISSNLinking>1744-8069</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>76I7G6D29C</RegistryNumber>
                <NameOfSubstance UI="D009020">Morphine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.1.1.6</RegistryNumber>
                <NameOfSubstance UI="D002394">Catechol O-Methyltransferase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002394" MajorTopicYN="N">Catechol O-Methyltransferase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009020" MajorTopicYN="N">Morphine</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017288" MajorTopicYN="N">Pain Threshold</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2008</Year>
                <Month>10</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2008</Year>
                <Month>12</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2008</Year>
                <Month>12</Month>
                <Day>20</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2008</Year>
                <Month>12</Month>
                <Day>20</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2009</Year>
                <Month>3</Month>
                <Day>28</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">19094200</ArticleId>
            <ArticleId IdType="pii">1744-8069-4-64</ArticleId>
            <ArticleId IdType="doi">10.1186/1744-8069-4-64</ArticleId>
            <ArticleId IdType="pmc">PMC2644687</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Pain. 2000 Nov;88(2):161-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11050371</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Hum Genet. 2001 Apr;68(4):978-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11254454</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pain Symptom Manage. 2002 Mar;23(3):239-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11888722</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anesth Analg. 2002 Jun;94(6):1598-605, table of contents</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12032036</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2002 Jun 21;296(5576):2225-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12029063</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pain Symptom Manage. 2002 Nov;24(5):517-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12547051</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2003 Feb 1;12(3):205-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12554675</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2003 Feb 21;299(5610):1240-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12595695</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Hum Genet. 2003 Nov;73(5):1162-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14574645</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Palliat Med. 2003 Dec;17(8):679-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14694919</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Psychiatr Res. 1975 Nov;12(3):189-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1202204</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pain. 1983 Oct;17(2):197-210</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6646795</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 1993 Mar 3;85(5):365-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8433390</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscience. 1993 Jun;54(3):669-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8101360</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1995 Jan 21;310(6973):170</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7833759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochemistry. 1995 Apr 4;34(13):4202-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7703232</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tissue Antigens. 1995 Nov;46(5):355-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8838344</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1998 Apr 18;316(7139):1236-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9553006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Brain Res. 1998 Nov;123(1-2):60-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9835393</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2005 Jan 1;14(1):135-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15537663</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pain. 2005 Jul;116(1-2):73-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15927391</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacogenomics J. 2005;5(5):324-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16103897</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Genet. 2006 Aug;43(8):e40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16882734</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Pain. 2006;2:24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16848906</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prog Neurobiol. 2006 Oct;80(2):53-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17030082</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2006 Dec 22;314(5807):1930-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17185601</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2008 Mar 15;112(6):1390-403</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18257092</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>